New York, NY-The ACUITY trial, suggesting that bivalirudin is an alternative to heparin/enoxaparin plus a glycoprotein (GP) IIb/IIIa inhibitor in moderate- or high-risk ACS patients undergoing an ...
NIAGARA FALLS, N.Y., May 25, 2021 /PRNewswire/ — The Harris OnPoint business unit of Harris Computer welcomes Mount Sinai South Nassau as a new AcuityPlus partner. As a facility that has established a ...
SHEBOYGAN - Sheboygan-based Acuity is the overall winner of the 2022 Award in Innovation, presented by the National Association of Mutual Insurance Companies, making the company the only insurer in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback